ClinicalTrials.Veeva

Menu

Myocardialbridge Bypass Graft Surgery Efficacy Verification

X

Xi'an International Medical Center Hospital

Status

Enrolling

Conditions

Myocardial Ischemia
Bypass Graft Occlusion
Bypass Graft Stenosis
Myocardial Bridging
Myocardial Bridge of Coronary Artery
Pectoris, Stable Angina
Myocardial Bridge
Bypass Graft Thrombosis
Myocardial Infarction
Sudden Cardiac Death

Treatments

Procedure: MB unroof
Procedure: MB CABG
Procedure: MBBG

Study type

Interventional

Funder types

Other

Identifiers

NCT06857838
XianInternationalMCH

Details and patient eligibility

About

Myocardial Bridge Bypass Graft surgery is introduced to relieve the unmedical symptoms of patients with long-segment or deep myocardial bridge, clinical outcomes will be collected to verify the effectiveness of the surgery.

Enrollment

500 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with myocardialbridge requiring drug therapy or surgical intervention.

Exclusion criteria

  • patients with myocardialbridge not requiring drug therapy or surgical intervention, or unwilling to be enrolled for any reason

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

500 participants in 3 patient groups

MyocardialBridge Bypass Graft
Experimental group
Description:
The patients with deep(depth\>2mm) and long-segement(length\>25mm) of myocardialbridge receiving myocardialbridge bypass graft surgery(MBBG),fulfilling the following criteria: 1.presenting with pectoris angina that cannot be effectively relieved by maximum guideline-directed drug therapy; 2. No atherosclerotic plaque or merely mild atherosclerotic stenosis is detected at the proximal or entry of the myocardialbridge confirmed by coronory artery angiography.
Treatment:
Procedure: MBBG
Myocardialbridge CABG
Active Comparator group
Description:
The patients with deep(depth\>2mm) and long-segement(length\>25mm) of myocardialbridge will be allocated to receive myocardialbridge bypass graft surgery(MBBG),when fulfilling the following criteria: 1.presenting with pectoris angina that cannot be effectively relieved by maximum guideline-directed drug therapy; 2. The moderate-to-severe atherosclertotic stenosis is detected at the proximal or entry of the myocardialbridge confirmed by coronory artery angiography.
Treatment:
Procedure: MB CABG
Myocardioalbridge Unroof
Active Comparator group
Description:
The patients with superficial type(depth\<2mm) and short-segement(length\<25mm) of myocardial bridge will be allocated to receive "unroof" surgery,when fulfilling the following criteria: 1.presenting with pectoris angina that cannot be effectively relieved by maximum guideline-directed drug therapy; 2. No atherosclerotic plaque or merely mild atherosclerotic stenosis is detected at the proximal or entry end of the myocardialbridge confirmed by coronory artery angiography.
Treatment:
Procedure: MB unroof

Trial contacts and locations

1

Loading...

Central trial contact

Jinzhou Zhang, Doctorate; Zhen Wang, Doctorate

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems